Fourth Annual Chicago Supportive Oncology Conference Sponsor and Grant Opportunities

Learning Objectives • Provide the rationale for integrating supportive and palliative care for patients with cancer earlier in the course of treatment and throughout the course of their disease • Identify novel approaches to improving cancer pain management, including use of opioids or analgesics for control of neuropathy and cytokine-based therapy • Detect common skeletal-related complications of cancer and cancer therapy, new pathways for treatment of bone metastases, and management of treatmentrelated adverse events • Characterize symptoms seen in the post-transplant setting, such as late neurologic effects and GVHD, and current approaches for their management • Recognize toxicities related to aggressive therapy, such as aromatase inhibitors and biologic therapies like IL-2 and EGFR inhibitors, mechanisms underlying these toxicities, and current strategies for their management • Define major treatment-related issues for patients with advanced head and neck cancer and approaches for integrating their management with overall oral care • Restate current models of the mechanisms underlying cancer-related mucositis, constipation, and cachexia and list therapies targeting these pathways • Distinguish common treatment issues in breast cancer patients, such as sexual dysfunction with hormonal therapy and cardiotoxicity with anthracyclines and trastuzumab, and how best to prevent or manage these toxicities • State the effects that cancer and its treatment can have on psychosocial aspects of patient care, including depression and grief, as well as cognitive function

Table of Contents Feed for the Digital Edition of Fourth Annual Chicago Supportive Oncology Conference Sponsor and Grant Opportunities

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.